Pulmonx (LUNG) Capital Expenditures (2019 - 2025)
Pulmonx's (LUNG) quarterly Capital Expenditures came in at $80000.0 in Q3 2025, down 80.77% year-over-year from $416000.0 in Q3 2024, and up 900.0% quarter-over-quarter from -$10000.0 in Q2 2025.
Powered by 
Analysis
Pulmonx (LUNG) Capital Expenditures (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Capital Expenditures for 7 consecutive years, with $80000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Capital Expenditures fell 80.77% year-over-year to $80000.0 in Q3 2025; TTM through Sep 2025 was $550000.0, a 64.19% decrease from a year earlier, with the FY2024 full-year figure at $1.4 million, up 79.31% from the prior year.
- Capital Expenditures was $80000.0 for Q3 2025 at Pulmonx, up from -$10000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.6 million in Q3 2021 and troughed at -$19000.0 in Q2 2023.
- A 5-year average of $404315.8 and a median of $299000.0 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures plunged 106.35% in 2023 and surged 2568.42% in 2024, its largest moves.
- Over 5 years, Capital Expenditures stood at $1.1 million in 2021, then tumbled by 84.67% to $176000.0 in 2022, then rose by 13.64% to $200000.0 in 2023, then tumbled by 44.5% to $111000.0 in 2024, then declined by 27.93% to $80000.0 in 2025.
- The last three Capital Expenditures figures came in at $80000.0 (Q3 2025), -$10000.0 (Q2 2025), and $369000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Pulmonx | 75.94 Mn | 6.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 111,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 469,000.00 |
| Mar 31, 2024 | 451,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | -19,000.00 |
| Mar 31, 2023 | 469,000.00 |
| Dec 31, 2022 | 176,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 564,000.00 |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 661,000.00 |
| Mar 31, 2021 | 242,000.00 |
| Dec 31, 2020 | 623,000.00 |